APA (7th ed.) Citation

F, S., JP, S., & MC, B. (2026). Ligand-based CAR design enhances durability of CD70-targeted CAR T cells in glioblastoma. Molecular therapy. Oncology, 34(1), 201150. https://doi.org/10.1016/j.omton.2026.201150

Chicago Style (17th ed.) Citation

F, Strassheimer, Steinbach JP, and Burger MC. "Ligand-based CAR Design Enhances Durability of CD70-targeted CAR T Cells in Glioblastoma." Molecular Therapy. Oncology 34, no. 1 (2026): 201150. https://doi.org/10.1016/j.omton.2026.201150.

MLA (9th ed.) Citation

F, Strassheimer, et al. "Ligand-based CAR Design Enhances Durability of CD70-targeted CAR T Cells in Glioblastoma." Molecular Therapy. Oncology, vol. 34, no. 1, 2026, p. 201150, https://doi.org/10.1016/j.omton.2026.201150.